[1] |
LU Renquan, LIU Guangyu, YANG Wentao, GUO Lin, GUAN Ming, SHAO Zhimin, XU Dazhi, NI Ming, TANG Feng, WANG Chaofu, LOU Jiatao, SUN Fenyong, XING Jinliang, PAN Yueyin.
Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy
[J]. China Oncology, 2022, 32(1): 90-96.
|
[2] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[3] |
DING Gaofeng, GUO Leiming, LU Yufei.
The relationship between expressions of HER2 and BRCA1 and radiotherapy sensitivity in breast cancer patients
[J]. China Oncology, 2021, 31(7): 589-595.
|
[4] |
GUO Ye , ZHANG Chenping .
Expert consensus on the treatment of recurrent/metastatic squamous cell carcinoma of the head and neck with anti-EGFR monoclonal antibody (2021 edition)
[J]. China Oncology, 2021, 31(12): 1220-1232.
|
[5] |
PAN Jian, WEI Yu, YE Dingwei, ZHU Yao.
Correlation between EGFR (rs884419) gene polymorphism and clinicopathological characteristics of prostate cancer
[J]. China Oncology, 2021, 31(11): 1104-1109.
|
[6] |
HE Xi, JIAO Xiaodong, ZANG Yuansheng.
Clinical research progress of tumor mutational burden in EGFR-mutant advanced non-small cell lung cancer
[J]. China Oncology, 2021, 31(1): 69-75.
|
[7] |
ZHU Lihua , NI Tingting , FAN Xingwen , WU Kailiang .
Comparison of prognostic scoring systems in patients with EGFR-mutant lung cancer and brain metastases
[J]. China Oncology, 2020, 30(8): 605-610.
|
[8] |
SHI Zhiqiang , QIU Pengfei , LIU Yanbing , ZHAO Tong , SUN Xiao , CHEN Peng , WANG Chunjian , ZHANG Zhaopeng , CONG Binbin , WANG Yongsheng .
Selective elimination of axillary surgery staging after neoadjuvant chemotherapy for HER2 positive and triple-negative breast cancer
[J]. China Oncology, 2020, 30(3): 186-191.
|
[9] |
WU Jia, ZHOU Jialiang.
The use of cetuximab in the continuum of care for patients with metastatic colorectal cancer
[J]. China Oncology, 2020, 30(1): 64-69.
|
[10] |
ZHU Chuanying, JIANG Mawei, ZHOU Renhua, LU Dongqing, ZHOU Qing.
Clinical study of nimotuzumab combined with chemoradiotherapy in the patients with pediatric brain stem gliomas
[J]. China Oncology, 2019, 29(9): 730-735.
|
[11] |
SUN Jianda, XIONG Jun, ZHANG Hanxiong, CHEN Yibiao.
Prognostic values of hematological biomarkers in locoregionally advanced nasopharyngeal carcinoma
[J]. China Oncology, 2019, 29(7): 528-534.
|
[12] |
LI Wencheng, WANG Xiaoshen.
The selection and application of platinum drugs in the treatment of head and neck squamous cell carcinomas
[J]. China Oncology, 2019, 29(4): 300-306.
|
[13] |
CHEN Dongfang, TENG Haohua, ZHAO Ruiying, et al.
Small cell lung cancer transformation from T790M-mutant lung adenocarcinoma following osimertinib treatment
[J]. China Oncology, 2018, 28(12): 935-939.
|
[14] |
DAI Xi, LI Guoping, YANG Xiaoqiong, et al.
Effects of Lyn kinase on EGFR signaling pathway in lung adenocarcinoma
[J]. China Oncology, 2018, 28(1): 43-49.
|
[15] |
GUO Ye.
The immunotherapy for head and neck cancer
[J]. China Oncology, 2017, 27(6): 459-462.
|